Reshaping Engagement in a Digital-First World

Digital channels, health data, and evolving expectations have already reshaped how consumers, patients, and HCPs engage with pharma. Now AI is changing something more fundamental – how health information is discovered, evaluated and trusted. Increasingly, customer experiences begin with an AI-generated answer before they reach a brand owned or earned channel. This panel explores what this means for engagement, personalization, trust, compliance, and how we measure influence in a digital-first world.

• Reach audiences at all points of discovery, where an AI-generated answer may be the first interaction with a brand or condition.

• Protect accuracy and fair balance while navigating the line between education, information, and promotion.

• Measure influence you can’t see directly, developing new signals for visibility and share of voice across channels